Research ExplorerScientific StaffFrancis Ayuketang Ayuk

PD Dr. med. ID: 49552

Francis Ayuketang Ayuk

graph of relations
Affiliations

Publications

Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study)

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis

Research output: SCORING: Contribution to journal › Case report › Research › peer-review

Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Axicabtagene ciloleucel versus tisagenlecleucel for relapsed or refractory large B-cell lymphoma: a systematic review and meta-analysis

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Development and Validation of a Prediction Model of Outcome After B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Autologous-allogeneic versus autologous tandem stem cell transplantation and maintenance therapy with thalidomide for multiple myeloma patients under 60 years of age: a prospective phase II study

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

View all (219)